Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes (SUSTAIN SWITCH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04287179
Recruitment Status : Withdrawn (COVID19 impact on this trial was evaluated and a delay of at least 6-9 months was expected. In parallel, the development of a new type of pen injector, which was an important part of the trial, was ceased and thus this trial was cancelled.)
First Posted : February 27, 2020
Last Update Posted : March 9, 2021
Information provided by (Responsible Party):
Novo Nordisk A/S

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : November 16, 2020
Estimated Study Completion Date : January 25, 2021